Div Gupta

Partner

+1 212 479 6474
dgupta@cooley.com

Div Gupta's practice focuses on the representation of public and private emerging growth companies and investment banking firms. He has handled a variety of significant business transactions, including public offerings of equity, high yield debt and convertible debt, venture capital financings, and mergers and acquisitions. He also advises a number of private companies as well as public companies on securities and general corporate matters.

Download full bio

Experience

  • Prevail Therapeutics Closes $50 Million Series B 

  • Innate Pharma - $79 Million IPO 

  • SpringWorks Therapeutics – $186 Million IPO  

  • Bellus Health – $70 Million IPO  

  • Karuna Therapeutics $103 million IPO 

  • View all

Education

  • Harvard Law School
    JD, cum laude, 2000

  • Yale University
    BS, magna cum laude, Phi Beta Kappa, 1997


Admissions & Credentials

California

New York

Texas

Rankings & Accolades

    Law 360 Rising Star (2015)

    Who's Who Legal: Life Sciences (2018)

Contact

+1 212 479 6474 office
dgupta@cooley.com

55 Hudson Yards
New York, NY 10001-2157